SGMT - Sagimet Biosciences Inc
5.74
0.210 3.659%
Share volume: 360,132
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$5.53
0.21
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-12-2025 | 05-08-2025 | 11-13-2025 | |
| Cash flow financing | 104.846 M | -27.000 K | 0.000 | 0.000 | 0.000 | 274.000 K | |
| Other financing cash flows | 114.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 274.000 K | |
| Cash flow | 101.638 M | -80.818 M | 0.000 | 0.000 | -11.123 M | -9.831 M | |
| Net income | -6.629 M | -8.118 M | -14.619 M | -16.201 M | -18.176 M | -12.908 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 3.000 M | -75.157 M | 624.000 K | 9.850 M | 3.413 M | 75.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 101.638 M | -80.818 M | -18.945 M | -1.174 M | -11.123 M | -9.831 M |